JP2024520650A - 特発性肺線維症の処置におけるカプサイシン誘導体 - Google Patents

特発性肺線維症の処置におけるカプサイシン誘導体 Download PDF

Info

Publication number
JP2024520650A
JP2024520650A JP2023574384A JP2023574384A JP2024520650A JP 2024520650 A JP2024520650 A JP 2024520650A JP 2023574384 A JP2023574384 A JP 2023574384A JP 2023574384 A JP2023574384 A JP 2023574384A JP 2024520650 A JP2024520650 A JP 2024520650A
Authority
JP
Japan
Prior art keywords
compound
straight chain
group
alkyl
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574384A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022253884A5 (enExample
Inventor
ラガー、エリック
アルテポスト、ルーカス
ヘルシング、トルステン
フラムロゼ、ボミ
Original Assignee
アクシケム アクチエボラグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクシケム アクチエボラグ filed Critical アクシケム アクチエボラグ
Publication of JP2024520650A publication Critical patent/JP2024520650A/ja
Publication of JPWO2022253884A5 publication Critical patent/JPWO2022253884A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2023574384A 2021-06-02 2022-06-01 特発性肺線維症の処置におけるカプサイシン誘導体 Pending JP2024520650A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20210693 2021-06-02
NO20210693A NO346587B1 (en) 2021-06-02 2021-06-02 Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis
PCT/EP2022/064876 WO2022253884A1 (en) 2021-06-02 2022-06-01 Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis

Publications (2)

Publication Number Publication Date
JP2024520650A true JP2024520650A (ja) 2024-05-24
JPWO2022253884A5 JPWO2022253884A5 (enExample) 2025-05-01

Family

ID=82115682

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574384A Pending JP2024520650A (ja) 2021-06-02 2022-06-01 特発性肺線維症の処置におけるカプサイシン誘導体

Country Status (6)

Country Link
US (1) US20240277637A1 (enExample)
EP (1) EP4346789A1 (enExample)
JP (1) JP2024520650A (enExample)
CN (1) CN117412742A (enExample)
NO (1) NO346587B1 (enExample)
WO (1) WO2022253884A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO348880B1 (en) * 2023-03-13 2025-06-30 Axichem Ab Physical performance aid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237423A1 (de) * 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen
NO20034069L (no) * 2003-09-12 2005-03-14 Aximed As Fremstilling og bruk av capsaicinderivater
CA2840932C (en) * 2011-07-07 2020-01-21 Eva MILLQVIST Cough reducing product
WO2015160842A1 (en) * 2014-04-14 2015-10-22 Flex Pharma, Inc. Methods and formulatiions of capsaicinoids and capsinoids
WO2017160156A1 (en) * 2016-03-18 2017-09-21 Axichem Ab Synthetic capasaicin analogs as trpv1 agonists
JP7412424B2 (ja) * 2018-09-18 2024-01-12 ブリストル－マイヤーズ スクイブ カンパニー Ｌｐａアンタゴニストとしてのオキサビシクロ酸
WO2020160225A1 (en) * 2019-01-30 2020-08-06 Ohio State Innovation Foundation ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
WO2020191501A1 (en) * 2019-03-27 2020-10-01 Algernon Pharmaceuticals Inc. Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders
WO2020227331A1 (en) * 2019-05-06 2020-11-12 Inspira, LLC Chemical entities, pharmaceutical formulations, and methods for treating fibrosis
WO2020259528A1 (zh) * 2019-06-25 2020-12-30 北京泰德制药股份有限公司 治疗特发性肺纤维化的方法
NO20200333A1 (en) * 2020-03-20 2021-03-29 Axichem As Synthesis of capsaicin derivatives

Also Published As

Publication number Publication date
CN117412742A (zh) 2024-01-16
NO346587B1 (en) 2022-10-17
WO2022253884A4 (en) 2023-01-12
WO2022253884A1 (en) 2022-12-08
NO20210693A1 (enExample) 2022-10-17
US20240277637A1 (en) 2024-08-22
EP4346789A1 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
ES2741439T3 (es) Compuestos aromáticos sustituidos
US20220152057A1 (en) Methods and compositions for treating various disorders
EA004657B1 (ru) Фармацевтическая композиция на основе обладающих антихолинергическим действием соединений , способ ее получения и применение
US20180214400A1 (en) The use of kauranes compounds in the manufacture of medicament for treatment of cadiac hypertropy and pulmonary hypertension
EP1225878B1 (en) Rar-gamma selective retinoid agonists for the treatment of emphysema
US20170209464A1 (en) Combinations of formoterol and budesonide for the treatment of copd
JP7695246B2 (ja) アルツハイマー病の治療のための化合物
JP2024520650A (ja) 特発性肺線維症の処置におけるカプサイシン誘導体
JP2023524229A (ja) 呼吸困難に起因する集中治療後の認知機能障害及び認知障害の予防及び治療のための化合物
EP4623908A1 (en) Use of (-)-epigallocatechin gallate compound
US20250161250A1 (en) Compositions and methods for treatment of idiopathic pulmonary fibrosis
JP2021075470A (ja) 肺線維症の予防または治療のための医薬
JP2021176903A (ja) イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用
WO2021209003A1 (en) Prevention and treatment of organ injuries
JP5670006B2 (ja) 去痰剤を含有する医薬組成物
KR20090046746A (ko) 만성 폐쇄성 폐 질환을 치료하기 위한 에르도스테인 및 베타-2 작용제의 조합물
TW202504602A (zh) 用於治療臟器纖維化相關疾病的藥物組合物和方法
JP6935930B2 (ja) 生薬成分を含む肺高血圧症の予防又は治療剤
CN118354761A (zh) 包含布洛芬和精氨酸的药物组合物
WO2025250560A1 (en) Methods for treating bronchiectasis
JP2018039748A (ja) 変異を有するｉ型コラーゲンの小胞体内過剰蓄積正常化剤
JP2025504768A (ja) 神経疾患の予防または治療のためのイオン液体ベースの製剤
JP5702349B2 (ja) 去痰剤を含有する医薬組成物
NZ579186A (en) A carbostyril derivative with probucol for treating chronic obstructive pulmonary disease
JPWO2017177966A5 (enExample)

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A525

Effective date: 20240131

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250422

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250422